Development and Validation of a Telemonitoring System for High-risk Cardiovascular Patients
NCT ID: NCT05485532
Last Updated: 2024-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
1000 participants
OBSERVATIONAL
2021-01-01
2028-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main purpose of this study is to investigate the beneficial effect of continuous telemonitoring in patients with cardiovascular diseases in different clinical settings (hospitalized patients, ambulant patients, patients during cardiac rehabilitation,...) Beside established risk parameters such as HRV (heart rate variability) and DC (Deceleration Capacity) new risk stratification models should be established from the continuously recorded biosignals.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Integrated Telemonitoring and Nurse Support Evaluation
NCT01700218
Remote Symptom Review in Patients With Implantable Diagnostic Holter
NCT06431828
Suitability of Unobtrusive Bed Monitoring and Wrist-worn Heart Rate Monitor for Patient Monitoring
NCT03572751
Telemedicine in Outpatient Covid-19 Patients
NCT04471636
Necklace-Shaped Sensor for Non-Invasive Remote Monitoring of Vitals
NCT02337790
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telemonitoring System using Cosinuss° Two and/or Garmin Vivoactive 4
Development and validation of a telemonitoring system using smart devices
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* cardiovascular disease with at least one of the following criteria:
* LVEF ≤ 40%
* cardiac autonomic dysfunction
* St. p. myocardial infarction
* St. p. cardiopulmonary resuscitation
* St. p. pulmonalartery embolism
* St. p. decompensated heart failure
* Informed consent for participation in the clinical trial
Exclusion Criteria
* pregnant and breast-feeding women
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University Innsbruck
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Univ. Prof. Dr. Axel Bauer
Director of Department for Internal Medicine III - Cardiology and Angiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medizinische Universität Innsbruck, Univ.-Klinik für Innere Medizin III, Kardiologie und Angiologie
Innsbruck, Tyrol, Austria
Reha Zentrum Münster
Münster, Tyrol, Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1282/2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.